HOME >> MEDICINE >> NEWS
Overweight Hispanic youth face increased risk of diabetes, metabolic syndrome

xplained Dr. Martha Cruz, the primary author on the study and an Assistant Professor at the University of Southern California. "We hope that our research will help the medical community better understand how to determine which children are at risk for developing diabetes, metabolic syndrome and cardiovascular disease."

The researchers studied 126 overweight Hispanic children between the ages of eight and 13 with a family history of type 2 diabetes. The metabolic syndrome was defined as having at least three of the following--abdominal obesity, low HDL-cholesterol, hypertriglyceridemia, hypertension or impaired glucose tolerance (IGT). They discovered that 90 percent of the subjects had at least one feature of the metabolic syndrome. Furthermore, 30 percent had three or more risk factors and had the metabolic syndrome. These findings show that overweight Hispanic youth are at an increased risk for developing type 2 diabetes and cardiovascular disease. Furthermore, the data suggested that greater levels of insulin resistance were associated with higher risk.

"Along with the high rates of the metabolic syndrome and the conditions associated with this disease, we found a direct association between insulin resistance, which is linked to diabetes, and HDL or "good" cholesterol, triglycerides and blood pressure, independent of body fat," explained Dr. Cruz. "These results suggest that in Hispanic youth with a family history of diabetes, insulin resistance directly contributes to the development of metabolic syndrome and is associated with an adverse metabolic profile."

The researchers noted that work should be done to improve insulin resistance in Hispanic youth in order to help lower the risk of type 2 diabetes and premature cardiovascular disease. They suggested that future research efforts focus on improving insulin through exercise, diet and, especially in those at greatest risk with the use of pharmacological agents.

In a second analy
'"/>

Contact: Marisa Lavine
mlavine@endo-society.org
301-941-0255
The Endocrine Society & The Hormone Foundation
12-Jan-2004


Page: 1 2 3 4

Related medicine news :

1. Overweight, boozy and depressed: Why we need healthy new years resolutions
2. Overweight men spend more on prescription drugs than normal-weight men
3. Overweight and obesity thresholds may be misleading for Asian populations
4. Overweight boys outweigh girls in stress response, study finds
5. Half-million cosmetic plastic surgery procedures for Hispanics in 2004 - up 49% from 2000
6. Chemistry and Flavor of Hispanic Foods one-day symposium, March 15
7. eDocAmerica launches Hispanic Website for members
8. English-speaking Hispanic youth more likely to have sex early
9. New study of African-American and Hispanic colorectal cancer patients
10. Black and Hispanic patients wait longer for heart attack treatment
11. Mexican Americans at greater risk for stroke than non-Hispanic whites

Post Your Comments:
(Date:10/22/2014)... Akeso Biomedical, Inc. , a privately held ... infections, microbial biofilms, and chronic wounds, announced that Dr. ... , Dr. Sinskey is a Professor ... of Technology, or MIT. He has been a member ... holds positions as Co-Director of the Malaysia-MIT Biotechnology Partnership ...
(Date:10/22/2014)... TUESDAY, Oct. 21, 2014 (HealthDay News) -- Two sisters ... and heart damage. Ilina and Medha Krishen use ... for sounds of trouble in breathing patterns or heartbeats. ... School in Michigan, wanted to find a way to ... air pollutants. Using an electronic stethoscope, Ilina recorded one ...
(Date:10/22/2014)... 2014 (HealthDay News) -- Measures taken by Firestone officials ... Liberia may have limited the spread of the disease ... The Firestone Natural Rubber Co. provides health services to ... nearby densely populated communities. Between Aug. 1 and ... cases among those 80,000 people. That incidence rate of ...
(Date:10/20/2014)... 20, 2014 The newly updated Worldwide ... of thousands of facts, figures and forecasts on the ... medical sector forecast categories the Worldwide Medical Market ... and national views on the worldwide medical market to ... report gives you data for 2010-2019, covering each country ...
(Date:10/20/2014)... October 20, 2014 The Advocator ... booth at the American Foundation for Suicide Prevention’s (AFSP) ... AFSP is a not-for-profit organization that hosts hundreds of ... from these events are used to help understand and ... and personal relationships as well. , The Advocator ...
Breaking Medicine News(10 mins):Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Teen Sisters Develop Ways to Measure Lung, Heart Damage 2Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 3Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 4Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 2Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 3
(Date:10/22/2014)... October 22, 2014 Oramed ... a clinical-stage pharmaceutical company focused on the development ... top-line clinical results from its Phase IIa clinical ... capsules, to treat type 1 diabetes. The trial was ... under a U.S. Food and Drug Administration ...
(Date:10/22/2014)... Colo. , Oct. 22, 2014   Surefire ... of infusion systems designed to maximize targeted delivery of ... pleased to announce that oncologist John R. Daniels ... Comprehensive Cancer Center, and surgical oncologist Steven C. ... have joined the Company,s Scientific Advisory Board (SAB).    ...
(Date:10/22/2014)... NEW YORK , Oct. 22, 2014 ... and dermatology therapies. PV-10, its novel investigational drug for ... the potential for systemic side effects. Its oncology focus ... liver. Provectus has completed phase 2 trials of PV-10 ... as a topical treatment for atopic dermatitis and psoriasis. ...
Breaking Medicine Technology:Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 4Surefire Medical's Scientific Advisory Board Expands, Broadens Clinical Trial Expertise 2Provectus Biopharmaceuticals Looks at the Asian Markets: Analyst Coverage by Small Cap Traders 2
Cached News: